Author Information
Jedd David Wolchok is a prominent figure in the field of cancer research, currently affiliated with the Swim Across America-Ludwig Collaborative Research Laboratory, Department of Medicine at Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College in New York, NY, USA. He is also part of the Immunology Program at the Ludwig Center for Cancer Immunotherapy. His research primarily focuses on cancer immunotherapy, particularly in the development and application of immune-based treatments for melanoma and other cancers.Research Contributions
Jedd David Wolchok has made significant contributions to the field of cancer immunotherapy. His work includes pioneering studies on checkpoint blockade therapies, which have revolutionized the treatment of melanoma. In 2022, his research explored various aspects of tumor immunology, including the identification of tumor-reactive T cells, the role of neoantigen-specific CD8 T cell responses in predicting therapy outcomes, and the impact of anatomic position on oncogenic specificity in melanoma. His efforts also extend to the innovative use of machine learning to enhance plasma tumor burden monitoring and pharmacologic modulation of RNA splicing to boost anti-tumor immunity.Aliases
Throughout his career, Jedd David Wolchok has published under several aliases, including J.d. Wolchok, Jedd Wolchok, J D Wolchok, Jedd D. Wolchok, J Wolchok, and J. D. Wolchok. These variations reflect the different ways his name has appeared in scientific literature.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
935 |
| Total Citations |
155,220 |
| H-index |
159 |
